fbpx

cgm

/Tag: cgm

Medtronic’s 670G Hybrid Closed Loop System: How to Customize Settings For The Best Performance

By |2019-02-09T17:20:07+00:00February 7th, 2019|Thinking Like A Pancreas Blog|

Medtronic’s Hybrid Closed Loop System: Getting More Bang For Your Buck By, Gary Scheiner MS, CDE, Jennifer Smith RD, LD, CDE, Alicia Downs RN, MSN, CDE, Annette Valle RN, CDE It’s been about a year and a half since we started using and training/managing patients on the Medtronic 670G “hybrid closed loop” system.  And we’ve learned a lot.  We’ve learned that 670G is beneficial for some, but it clearly isn’t for everybody.  Yes, for the “average” person with diabetes, it can produce improvements in glucose control while helping reduce the risk of dangerous hypoglycemia.  But there are limits to the degree of glucose control that can be achieved, and there are many hassles and extra tasks involved with using the system. There are other hybrid closed loop systems that are already in use, despite not being on the “FDA approved” list of systems. Loop and OpenAPS systems are highly effective for improving glucose control, but they require special equipment and an “app build” to get them up and running. Tandem’s T:Slim with Basal IQ is easy-as-pie to use, but it only turns off basal insulin to help prevent lows. Other systems are coming to market soon:  Tandem’s Control IQ, OmniPod’s Horizon, Tidepool Loop and BigFoot Biomedical’s system are all slated to make automated basal adjustments (similar to Medtronic’s 670G, but with less work on the part of the user), but until the pre-launch studies are completed and the FDA signs off, all we can do is picture them in our daytime fantasies. So for those who want 24-hour automated basal adjustment NOW that is FDA approved, that really leaves just one option:  670G. Medtronic has taking steps to cut down on some of the [...]

ADA Scientific Sessions 2018: Gary’s Top-5 Observations

By |2018-07-31T16:13:08+00:00July 24th, 2018|July 2018 Newsletter, Thinking Like A Pancreas Blog|

As usual, this year’s American Diabetes Association Scientific Sessions didn’t place much emphasis on a healthy lifestyle.  There was food everywhere, and trust me, we’re not talking fruits & veggies.  But there was a great deal of research presented on diabetes medications and devices. 

IDS Clinicians Offer Different Perspectives on the Medtronic 670G

By |2018-03-23T21:15:07+00:00March 21st, 2018|Diabetes Bites, March 2018 Newsletter, Thinking Like A Pancreas Blog|

IDS Clinicians Offer Different Perspectives on the Medtronic 670G after 10 days of use. Read what they have to say...

It’s Libre, Man! In-Depth Review of the Newly Approved Freestyle Libre

By |2018-04-19T19:57:00+00:00November 18th, 2017|November 2017 Newsletter, Thinking Like A Pancreas Blog|

Diabetes educator, Gary Scheiner gives his in-depth review of the newly approved Abbott Freestyle Libre CGM continuous glucose monitor.

670G and Me: Insights and Incites on Medtronic’s Latest System

By |2017-09-30T12:49:07+00:00September 29th, 2017|Thinking Like A Pancreas Blog|

The 670G represents an important step towards fully automating glucose control. However, it is important to put it in the proper context and set expectations at an appropriate level.

Medicare and Diabetes Technology Insurance Coverage

By |2016-10-14T19:10:39+00:00October 14th, 2016|Thinking Like A Pancreas Blog|

It's awesome that people with diabetes are living normal lifespans, but the current Medicare system is not set up to provide coverage of the technologies that we become accustomed to using when we have commercial insurance coverage to control the disease as well as we can.

Artificial Pancreas Systems – What’s in the Future?

By |2016-12-08T23:26:42+00:00July 19th, 2016|Thinking Like A Pancreas Blog|

There are a multitude of different groups working on hybrid closed loop projects, and each one runs on its own unique proportion of automation and brain-power. Here are a few of the projects that were presented and discussed at the ADA Scientific Sessions in New Orleans this past June.

Running a Marathon with type 1 diabetes

By |2016-12-08T23:26:42+00:00May 31st, 2016|Thinking Like A Pancreas Blog|

My name is Jacob Seltzer, I am 20 years old, and a Type 1 Diabetic. I was diagnosed with diabetes on my half birthday, November 21, 2011 at the age of 15. I have had diabetes for roughly 5 years and I do not let it get in my way. I am currently going into my junior year of college at Stony Brook University as an athletic training major.